COVID-19 and diabetes: Can DPP4 inhibition play a role?

Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
No abstract available

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / complications*
  • Diabetes Complications / drug therapy*
  • Diabetes Mellitus / drug therapy*
  • Dipeptidyl Peptidase 4 / metabolism*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Pandemics
  • Pneumonia, Viral / complications*
  • SARS-CoV-2

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4